ClinicalTrials.gg
TerminatedNCT04041258CLAPSUpdated Apr 15, 2022

"Evaluation of Clinical and Radiographic Results of Pseudarthrosis of Clavicle Treated With Plaque and Screws"

An interventional study of pseudoarthrosis of clavicle in Pseudoarthrosis of the Clavicle, sponsored by Istituto Ortopedico Rizzoli. Terminated at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-04-15.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

Why this study was terminated
the number of patients was not sufficient to support continuation of the study
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is an interventional study for clinical and radiographic evaluation of patients operated for pseudoarthrosis of the clavicle

Read the detailed description

The aim of our study is to collect clinical and radiographic data from patients operated for pseudoarthrosis of the clavicle from 2007 to 2017 at the Rizzoli Orthopedic Institute, in order to evaluate the clinical and radiographic results of the treatment. This is an interventional study and patients will be contacted by telephone to verify their willingness to perform a visit (including a bilateral radiographic) at the Rizzoli Orthopedic Institute

02

Conditions studied

  • Pseudoarthrosis of the Clavicle

Browse trials for

Keywords

  • pseudoarthrosis
  • clavicle
03

In context

Pseudarthrosis

41 studies on the registry are indexed under Pseudarthrosis; 7 are open to participants now.

This study's enrollment of 20 is close to the median of 22 across 25 interventional studies indexed under Pseudarthrosis.

Browse Pseudarthrosis studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18-65 years of pseudarthrosis intervention
  2. Males and Females
  3. Patients treated for pseudoarthrosis of the clavicle between 2007 and 2017 at the Rizzoli Orthopedic Institute

Exclusion criteria

Exclusion Criteria:

  1. Floating shoulder
  2. subjects who present to radiographic examination at the time of telephone contact
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    evaluation of clinical and radiographic findings after surgical treatment

    Evaluation of clinical and radiographic findings at least 1 year after surgical treatment for pseudoarthrosis of clavicle

    Procedure: pseudoarthrosis of clavicle

Interventions

  • Procedurepseudoarthrosis of clavicle

    Pseudoarthrosis represents a complication following a fracture, resulting in persistent symptoms and functional limitation, which prolongs the recovery time for the patient and necessitates new surgery. The purpose of surgery for pseudoarthrosis is to re-establish the length and alignment of the clavicle in an environment favorable to the union of bone fragments.

06

What researchers measure

Primary outcomes

  1. range of motion ROM

    improvement of range of motion measure (in grade)

    Time frame: at least 1 year of follow up

  2. presence of dyskinesias

    objective clinical evaluation (elevation, external rotation, abduction) with constant scale (0-25 points)

    Time frame: at least 1 year of follow up

  3. alteration of the clavicle length

    measure (mm) obtained from radiographic evaluation

    Time frame: at least 1 year of follow up

Secondary outcomes

  1. evaluate shoulder function

    improvement in Assessment Shoulder and Elbow Scale (ASES) (0-100 points)

    Time frame: at least 1 year of follow up

07

Study locations

1 site
  • Rizzoli Orthopaedic Institute
    Bologna, 40136, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2019 to primary completion in Jul 2020, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2019
First posted
Aug 1, 2019
StartActual
Jul 30, 2019
Primary completionActual
Jul 30, 2020
CompletionActual
May 1, 2021
Last update
Apr 15, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04041258
Responsible party
Sponsor
First posted
Aug 1, 2019
Start date
Jul 30, 2019
Primary completion
Jul 30, 2020
Completion
May 1, 2021
Last update
Apr 15, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion